Tratamiento conservador de la enfermedad de Peyronie: colchicina versus colchicina más vitamina E
2010
Objective: To retrospectively review the response of patients with Peyronie’s disease (PD) treated with colchicine as monotherapy and colchicine plus Vitamin E. Material and methods: We evaluated 100 men with PD. A dose of 1.5 mg/day oral Colchicine as monotherapy (CCM) was given to 59 patients and 1.5/800 mg/day oral Colchicine/Vitamin E (CCVE) to 41. Response was categorized as follows: Good response, when at least 2 of the
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
17
References
7
Citations
NaN
KQI